An Australian lab has claimed success in animal trials of a drug to ward off dementia.

Flinders University researchers are looking to develop effective immunotherapy via a dual vaccine to remove ‘brain plaque’ and tau protein aggregates linked to Alzheimer’s disease.

They say recent success in bigenic mouse models supports progression to human trials in years to come.

The experts are working on a new treatment to remove accumulated beta-amyloid (Aβ) plaques and neurofibrillary tangles composed of hyperphosphorylated tau, which together lead to neurodegeneration and cognitive decline in Alzheimer’s disease.

The latest findings are accessible here.